GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,386,197 | +186.0% | 1,664,502 | +312.1% | 0.00% | – |
| Q2 2023 | $484,641 | -71.1% | 403,867 | -69.7% | 0.00% | – |
| Q1 2023 | $1,678,096 | -56.3% | 1,331,822 | -24.7% | 0.00% | -100.0% |
| Q4 2022 | $3,838,333 | -69.5% | 1,768,817 | +68.2% | 0.00% | -66.7% |
| Q3 2022 | $12,597,000 | +135.0% | 1,051,512 | +64.1% | 0.00% | +200.0% |
| Q2 2022 | $5,361,000 | +35.4% | 640,589 | +40.5% | 0.00% | 0.0% |
| Q1 2022 | $3,958,000 | +43.4% | 455,892 | +86.8% | 0.00% | 0.0% |
| Q4 2021 | $2,761,000 | -61.6% | 244,088 | -57.3% | 0.00% | -50.0% |
| Q3 2021 | $7,189,000 | +73.1% | 571,917 | +11.8% | 0.00% | +100.0% |
| Q2 2021 | $4,154,000 | -54.0% | 511,575 | -47.6% | 0.00% | -50.0% |
| Q1 2021 | $9,038,000 | +9.6% | 977,097 | +14.6% | 0.00% | 0.0% |
| Q4 2020 | $8,243,000 | -18.1% | 852,354 | +5.1% | 0.00% | -33.3% |
| Q3 2020 | $10,066,000 | +346.8% | 811,164 | +368.0% | 0.00% | +200.0% |
| Q2 2020 | $2,253,000 | +198.8% | 173,332 | +133.2% | 0.00% | – |
| Q1 2020 | $754,000 | -51.0% | 74,327 | -24.6% | 0.00% | – |
| Q4 2019 | $1,540,000 | -28.6% | 98,561 | -1.0% | 0.00% | -100.0% |
| Q1 2019 | $2,157,000 | – | 99,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |